DEUTSCHE BANK AG\
BankPosition in AXSM — Axsome Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in AXSM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$21,164,281
+$3,541,244 QoQ
Shares Held
86,466
-17.1% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#78
of 503 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. AXSM ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in AXSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,164,281 | 86,466 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $17,623,037 | 104,266 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $17,945,657 | 98,257 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $11,743,242 | 96,692 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,696,785 | 92,890 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $11,077,515 | 94,980 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $10,199,480 | 120,547 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $7,886,810 | 87,758 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $6,456,341 | 80,203 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $6,633,294 | 83,124 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $6,355,419 | 79,852 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,196,614 | 60,046 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $4,141,938 | 57,639 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,000,503 | 64,859 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,705,633 | 48,044 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,026,684 | 45,421 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,773,787 | 46,313 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,008,614 | 48,529 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,889,188 | 50,005 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,644,281 | 80,227 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,116,516 | 46,198 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,230,170 | 57,050 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,332,980 | 53,185 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,327,873 | 46,707 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,780,024 | 45,941 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,761,065 | 46,933 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||